Breaking News Instant updates and real-time market news.

KIGRY

Kion Group

$0.00 /

+ (+0.00%)

12:54
08/12/20
08/12
12:54
08/12/20
12:54

Kion Group price target raised to EUR 79 from EUR 55 at Berenberg

Berenberg analyst Philippe Lorrain raised the firm's price target on Kion Group to EUR 79 from EUR 55 and keeps a Buy rating on the shares.

KIGRY Kion Group
$0.00 /

+ (+0.00%)

08/12/20 Berenberg
Kion Group price target raised to EUR 79 from EUR 55 at Berenberg
08/03/20 JPMorgan
Kion Group price target raised to EUR 56 from EUR 48 at JPMorgan
07/22/20 Deutsche Bank
Kion Group price target raised to EUR 75 from EUR 62 at Deutsche Bank
07/20/20 DZ Bank
Kion Group downgraded to Sell from Buy at DZ Bank

TODAY'S FREE FLY STORIES

Conference/Events
Jefferies software/Internet analyst to hold an analyst/industry conference call » 15:17
09/21/20
09/21
15:17
09/21/20
15:17

Software & Internet…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Technical Analysis
NASDAQ market internals summary » 15:17
09/21/20
09/21
15:17
09/21/20
15:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Technical Analysis
NYSE market internals summary » 15:16
09/21/20
09/21
15:16
09/21/20
15:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

Conference/Events
Jefferies software/Internet analyst to hold an analyst/industry conference call » 15:14
09/21/20
09/21
15:14
09/21/20
15:14

Software & Internet…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Downgrade
Illumina downgraded to Neutral after deal for Grail at JPMorgan » 15:12
09/21/20
09/21
15:12
09/21/20
15:12
ILMN

Illumina

$269.21 /

-26.08 (-8.83%)

JPMorgan analyst Tycho…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ILMN Illumina
$269.21 /

-26.08 (-8.83%)

ILMN Illumina
$269.21 /

-26.08 (-8.83%)

15:07 Today JPMorgan
Illumina downgraded to Neutral from Overweight at JPMorgan
14:33 Today Cowen
Illumina's GRAIL deal 'an unclear fit' with core competencies, says Cowen
06:11 Today Guggenheim
Illumina upgraded to Buy from Neutral at Guggenheim
09/17/20 Citi
Citi does not see strategic rationale in Illumina acquiring Grail
ILMN Illumina
$269.21 /

-26.08 (-8.83%)

ILMN Illumina
$269.21 /

-26.08 (-8.83%)

ILMN Illumina
$269.21 /

-26.08 (-8.83%)

ILMN Illumina
$269.21 /

-26.08 (-8.83%)

Downgrade
Illumina downgraded to Neutral from Overweight at JPMorgan » 15:07
09/21/20
09/21
15:07
09/21/20
15:07
ILMN

Illumina

$267.88 /

-27.41 (-9.28%)

JPMorgan analyst Tycho…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ILMN Illumina
$267.88 /

-27.41 (-9.28%)

ILMN Illumina
$267.88 /

-27.41 (-9.28%)

14:33 Today Cowen
Illumina's GRAIL deal 'an unclear fit' with core competencies, says Cowen
06:11 Today Guggenheim
Illumina upgraded to Buy from Neutral at Guggenheim
09/17/20 Citi
Citi does not see strategic rationale in Illumina acquiring Grail
09/09/20 Morgan Stanley
Illumina initiated with an Equal Weight at Morgan Stanley
ILMN Illumina
$267.88 /

-27.41 (-9.28%)

ILMN Illumina
$267.88 /

-27.41 (-9.28%)

ILMN Illumina
$267.88 /

-27.41 (-9.28%)

ILMN Illumina
$267.88 /

-27.41 (-9.28%)

Conference/Events
Stamps.com participates in a conference call with Craig-Hallum » 15:06
09/21/20
09/21
15:06
09/21/20
15:06
STMP

Stamps.com

$219.35 /

-6.54 (-2.90%)

Conference call with CFO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STMP Stamps.com
$219.35 /

-6.54 (-2.90%)

STMP Stamps.com
$219.35 /

-6.54 (-2.90%)

08/07/20 Northland
Stamps.com downgraded to Market Perform from Outperform at Northland
08/07/20 Craig-Hallum
Stamps.com price target raised to $340 from $300 at Craig-Hallum
08/03/20 Craig-Hallum
Stamps.com price target raised to $300 from $230 at Craig-Hallum
05/28/20 Northland
Northland keeps Outperform on Stamps.com, sees e-commerce volume to persist
STMP Stamps.com
$219.35 /

-6.54 (-2.90%)

STMP Stamps.com
$219.35 /

-6.54 (-2.90%)

STMP Stamps.com
$219.35 /

-6.54 (-2.90%)

Initiation
PNM Resources initiated with a Buy at Sidoti » 15:00
09/21/20
09/21
15:00
09/21/20
15:00
PNM

PNM Resources

$39.32 /

-0.72 (-1.80%)

Sidoti initiated coverage…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PNM PNM Resources
$39.32 /

-0.72 (-1.80%)

PNM PNM Resources
$39.32 /

-0.72 (-1.80%)

08/11/20 Wells Fargo
PNM Resources upgraded to Overweight from Equal Weight at Wells Fargo
06/03/20 Mizuho
PNM Resources price target raised to $45 from $43 at Mizuho
05/15/20 Barclays
Barclays upgrades Utilities sector along with PG&E and two others
05/15/20 Barclays
PNM Resources upgraded to Overweight from Equal Weight at Barclays
PNM PNM Resources
$39.32 /

-0.72 (-1.80%)

  • 08
    Jan
Conference/Events
scPharmaceuticals to host conference call » 15:00
09/21/20
09/21
15:00
09/21/20
15:00
SCPH

scPharmaceuticals

$7.50 /

+ (+0.00%)

Management holds a Key…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SCPH scPharmaceuticals
$7.50 /

+ (+0.00%)

SCPH scPharmaceuticals
$7.50 /

+ (+0.00%)

05/13/20 SVB Leerink
scPharmaceuticals price target raised to $12 from $7 at SVB Leerink
05/13/20 H.C. Wainwright
scPharmaceuticals price target raised to $15 from $13 at H.C. Wainwright
10/15/19 H.C. Wainwright
scPharmaceuticals initiated with a Buy at H.C. Wainwright
SCPH scPharmaceuticals
$7.50 /

+ (+0.00%)

  • 21
    May
SCPH scPharmaceuticals
$7.50 /

+ (+0.00%)

Recommendations
Regeneron's Libtayo delivered results on par with Keytruda, says Piper Sandler » 15:00
09/21/20
09/21
15:00
09/21/20
15:00
MRK

Merck

$82.34 /

-3.48 (-4.05%)

, SNY

Sanofi

$50.42 /

-2.01 (-3.83%)

, REGN

Regeneron

$547.45 /

-7.78 (-1.40%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRK Merck
$82.34 /

-3.48 (-4.05%)

SNY Sanofi
$50.42 /

-2.01 (-3.83%)

REGN Regeneron
$547.45 /

-7.78 (-1.40%)

MRK Merck
$82.34 /

-3.48 (-4.05%)

09/15/20 SVB Leerink
Seattle Genetics price target raised to $185 from $173 at SVB Leerink
09/14/20 RBC Capital
Seattle Genetics price target raised to $191 from $175 at RBC Capital
09/14/20 Piper Sandler
Seattle Genetics price target raised to $172 from $165 at Piper Sandler
08/11/20 H.C. Wainwright
Pfenex acquisition fits well with Ligand growing portfolio, says H.C. Wainwright
SNY Sanofi
$50.42 /

-2.01 (-3.83%)

09/14/20 Roth Capital
Immunic has 'significant' opportunity in RRMS, says Roth Capital
08/24/20 SVB Leerink
SVB Leerink continues to view Alexion as good M&A fit for number of suitors
08/19/20 Stifel
Principia Biopharma downgraded to Hold from Buy at Stifel
08/18/20 SVB Leerink
Principia Biopharma downgraded to Market Perform at SVB Leerink
REGN Regeneron
$547.45 /

-7.78 (-1.40%)

09/16/20 Canaccord
Eli Lilly COVID-19 data bodes well for Regeneron, says Canaccord
09/16/20 Goldman Sachs
Eli Lilly COVID-19 antibody data 'encouraging,' says Goldman Sachs
09/10/20 Benchmark
Vaccine may be approved before Regeneron's COVID therapeutic, says Benchmark
09/09/20 Jefferies
ASH data could prompt 40% rise, or 70% drop, for IGM Biosciences, says Jefferies
MRK Merck
$82.34 /

-3.48 (-4.05%)

SNY Sanofi
$50.42 /

-2.01 (-3.83%)

REGN Regeneron
$547.45 /

-7.78 (-1.40%)

  • 27
    May
MRK Merck
$82.34 /

-3.48 (-4.05%)

SNY Sanofi
$50.42 /

-2.01 (-3.83%)

REGN Regeneron
$547.45 /

-7.78 (-1.40%)

MRK Merck
$82.34 /

-3.48 (-4.05%)

SNY Sanofi
$50.42 /

-2.01 (-3.83%)

REGN Regeneron
$547.45 /

-7.78 (-1.40%)

MRK Merck
$82.34 /

-3.48 (-4.05%)

SNY Sanofi
$50.42 /

-2.01 (-3.83%)

REGN Regeneron
$547.45 /

-7.78 (-1.40%)

Hot Stocks
Ionis' treatment of Alexander disease granted FDA orphan designation » 14:58
09/21/20
09/21
14:58
09/21/20
14:58
IONS

Ionis Pharmaceuticals

$49.54 /

-1.85 (-3.60%)

Ionis…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IONS Ionis Pharmaceuticals
$49.54 /

-1.85 (-3.60%)

IONS Ionis Pharmaceuticals
$49.54 /

-1.85 (-3.60%)

09/14/20 JPMorgan
Ionis Pharmaceuticals resumed with a Neutral at JPMorgan
09/08/20 Citi
Ionis Pharmaceuticals price target lowered to $74 from $78 at Citi
09/02/20 Benchmark
Benchmark starts Ionis at Hold, cautious on Spinraza competition
09/02/20 Benchmark
Ionis Pharmaceuticals initiated with a Hold at Benchmark
IONS Ionis Pharmaceuticals
$49.54 /

-1.85 (-3.60%)

IONS Ionis Pharmaceuticals
$49.54 /

-1.85 (-3.60%)

Hot Stocks
RBC says aware of issue affecting telephone, online banking and mobile app » 14:55
09/21/20
09/21
14:55
09/21/20
14:55
RY

Royal Bank of Canada

$70.14 /

-2.32 (-3.20%)

In a tweeted reply to a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RY Royal Bank of Canada
$70.14 /

-2.32 (-3.20%)

RY Royal Bank of Canada
$70.14 /

-2.32 (-3.20%)

08/27/20 TD Securities
Royal Bank of Canada price target raised to C$110 from C$105 at TD Securities
08/27/20 Scotiabank
Royal Bank of Canada Q3 results show why it's widely regarded, says Scotiabank
08/27/20 CIBC
Royal Bank of Canada results support 'quality arguments,' says CIBC
08/27/20 Canaccord
Royal Bank of Canada price target raised to C$104.50 from C$95.50 at Canaccord
RY Royal Bank of Canada
$70.14 /

-2.32 (-3.20%)

RY Royal Bank of Canada
$70.14 /

-2.32 (-3.20%)

RY Royal Bank of Canada
$70.14 /

-2.32 (-3.20%)

Conference/Events
CytoDyn executives to participate in a webinar » 14:52
09/21/20
09/21
14:52
09/21/20
14:52
CYDY

CytoDyn

$0.00 /

+ (+0.00%)

CEO Dr. Pourhassan and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CYDY CytoDyn
$0.00 /

+ (+0.00%)

CYDY CytoDyn
$0.00 /

+ (+0.00%)

07/06/20 H.C. Wainwright
CytoDyn downgraded to Neutral from Buy at H.C. Wainwright
04/28/20 H.C. Wainwright
CytoDyn price target raised to $4 from $3 at H.C. Wainwright
04/03/20 H.C. Wainwright
CytoDyn price target raised to $3 from $1.50 at H.C. Wainwright
12/19/19 H.C. Wainwright
CytoDyn price target raised to $1.50 from $1.00 at H.C. Wainwright
CYDY CytoDyn
$0.00 /

+ (+0.00%)

CYDY CytoDyn
$0.00 /

+ (+0.00%)

General news
Wall Street remains sharply lower » 14:50
09/21/20
09/21
14:50
09/21/20
14:50

Wall Street remains…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
OptimizeRx to hold a webinar » 14:48
09/21/20
09/21
14:48
09/21/20
14:48
OPRX

OptimizeRx

$19.28 /

-0.73 (-3.65%)

Management holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OPRX OptimizeRx
$19.28 /

-0.73 (-3.65%)

OPRX OptimizeRx
$19.28 /

-0.73 (-3.65%)

09/14/20 Roth Capital
OptimizeRx price target raised to $40 from $30 at Roth Capital
08/06/20 Lake Street
OptimizeRx price target raised to $20 from $17 at Lake Street
08/06/20 B. Riley FBR
OptimizeRx price target raised to $28 from $22 at B. Riley FBR
06/10/20 Lake Street
OptimizeRx news strategically significant, broadens reach, says Lake Street
OPRX OptimizeRx
$19.28 /

-0.73 (-3.65%)

On The Fly
Fly Insider: Kingsway Financial, Nvidia among week's notable insider trades » 14:45
09/21/20
09/21
14:45
09/21/20
14:45
TDG

TransDigm

$488.85 /

-16.92 (-3.35%)

, ATNX

Athenex

$12.41 /

-0.73 (-5.56%)

, KFS

Kingsway Financial

$3.05 /

-0.075 (-2.40%)

, VOXX

VOXX

$7.76 /

-0.84 (-9.77%)

, GES

Guess

$12.40 /

-1.34 (-9.75%)

, NVDA

Nvidia

$491.00 /

+3.63 (+0.74%)

, AM

Antero Midstream

$5.29 /

-0.12 (-2.22%)

, PTON

Peloton

$93.00 /

+3.215 (+3.58%)

, RVLV

Revolve Group

$17.15 /

-0.17 (-0.98%)

, MNRL

Brigham Minerals

$9.25 /

-0.415 (-4.29%)

Welcome to "Fly Insider,"…

ShowHide Related Items >><<
TDG TransDigm
$488.85 /

-16.92 (-3.35%)

ATNX Athenex
$12.41 /

-0.73 (-5.56%)

KFS Kingsway Financial
$3.05 /

-0.075 (-2.40%)

GES Guess
$12.40 /

-1.34 (-9.75%)

NVDA Nvidia
$491.00 /

+3.63 (+0.74%)

AM Antero Midstream
$5.29 /

-0.12 (-2.22%)

PTON Peloton
$93.00 /

+3.215 (+3.58%)

RVLV Revolve Group
$17.15 /

-0.17 (-0.98%)

MNRL Brigham Minerals
$9.25 /

-0.415 (-4.29%)

TDG TransDigm
$488.85 /

-16.92 (-3.35%)

09/18/20 Jefferies
TransDigm more likely than Curtiss-Wright to buy Triumph, says Jefferies
09/17/20 Credit Suisse
TransDigm price target raised to $577 from $473 at Credit Suisse
09/10/20 Barclays
TransDigm price target raised to $550 from $445 at Barclays
09/08/20 Morgan Stanley
TransDigm initiated with an Overweight at Morgan Stanley
ATNX Athenex
$12.41 /

-0.73 (-5.56%)

09/01/20 RBC Capital
Athenex price target raised to $33 from $31 at RBC Capital
12/13/19 RBC Capital
Athenex oraxol OS and ORR a 'best case,' buy on weakness, says RBC Capital
12/06/19 SunTrust
Athenex initiated with a Buy at SunTrust
11/19/19 RBC Capital
Athenex gets 'third SABCS win' ahead of meeting, says RBC Capital
KFS Kingsway Financial
$3.05 /

-0.075 (-2.40%)

VOXX VOXX
$7.76 /

-0.84 (-9.77%)

GES Guess
$12.40 /

-1.34 (-9.75%)

06/17/20 B. Riley FBR
Guess price target lowered to $15 from $17 at B. Riley FBR
03/24/20 Cowen
Guess downgraded to Market Perform at Cowen
03/24/20 Cowen
Guess downgraded to Market Perform from Outperform at Cowen
03/09/20 Jefferies
Guess price target lowered to $21 from $27 at Jefferies
NVDA Nvidia
$491.00 /

+3.63 (+0.74%)

06:23 Today RBC Capital
Nvidia's GPU demand for 'crypto-mining' is back, says RBC Capital
09/18/20 Northland
Combined Nvidia-ARM a long-term risk for AMD, Intel and Vicor, says Northland
09/15/20 Needham
Nvidia price target raised to $700 from $600 at Needham
09/15/20 Craig-Hallum
Nvidia price target raised to $500 from $480 at Craig-Hallum
AM Antero Midstream
$5.29 /

-0.12 (-2.22%)

09/09/20 Goldman Sachs
Antero Midstream initiated with a Neutral at Goldman Sachs
08/10/20
Fly Intel: Top five analyst initiations
08/10/20 UBS
Antero Midstream initiated with a Neutral at UBS
05/01/20 Citi
Antero Midstream downgraded to Neutral from Buy at Citi
PTON Peloton
$93.00 /

+3.215 (+3.58%)

09/18/20 JPMorgan
Apple Fitness+ contribution will take time, says JPMorgan
09/16/20 Canaccord
Peloton on its way to connected fitness leadership, says Canaccord
09/16/20 Rosenblatt
Apple entrance not barrier to Peloton's growth, says Rosenblatt
09/16/20 Stifel
Peloton valuation framework supports 'four-year double,' says Stifel
RVLV Revolve Group
$17.15 /

-0.17 (-0.98%)

09/17/20 MKM Partners
Revolve Group initiated with a Buy at MKM Partners
09/16/20 MKM Partners
Revolve Group initiated with a Buy at MKM Partners
09/03/20 Roth Capital
Revolve Group initiated with a Buy at Roth Capital
08/14/20 DA Davidson
Revolve Group price target raised to $23 from $15 at DA Davidson
MNRL Brigham Minerals
$9.25 /

-0.415 (-4.29%)

09/14/20 Credit Suisse
Brigham Minerals upgraded to Outperform from Neutral at Credit Suisse
09/14/20 Credit Suisse
Brigham Minerals upgraded to Outperform from Neutral at Credit Suisse
07/23/20 Capital One
Brigham Minerals upgraded to Overweight from Equalweight at Capital One
07/20/20 Raymond James
Brigham Minerals upgraded to Strong Buy from Outperform at Raymond James
TDG TransDigm
$488.85 /

-16.92 (-3.35%)

ATNX Athenex
$12.41 /

-0.73 (-5.56%)

GES Guess
$12.40 /

-1.34 (-9.75%)

NVDA Nvidia
$491.00 /

+3.63 (+0.74%)

AM Antero Midstream
$5.29 /

-0.12 (-2.22%)

PTON Peloton
$93.00 /

+3.215 (+3.58%)

RVLV Revolve Group
$17.15 /

-0.17 (-0.98%)

MNRL Brigham Minerals
$9.25 /

-0.415 (-4.29%)

  • 11
    Sep
  • 11
    Sep
  • 10
    Sep
  • 10
    Jun
  • 12
    Dec
  • 07
    Nov
  • 26
    Sep
NVDA Nvidia
$491.00 /

+3.63 (+0.74%)

AM Antero Midstream
$5.29 /

-0.12 (-2.22%)

PTON Peloton
$93.00 /

+3.215 (+3.58%)

ATNX Athenex
$12.41 /

-0.73 (-5.56%)

VOXX VOXX
$7.76 /

-0.84 (-9.77%)

GES Guess
$12.40 /

-1.34 (-9.75%)

NVDA Nvidia
$491.00 /

+3.63 (+0.74%)

AM Antero Midstream
$5.29 /

-0.12 (-2.22%)

PTON Peloton
$93.00 /

+3.215 (+3.58%)

RVLV Revolve Group
$17.15 /

-0.17 (-0.98%)

MNRL Brigham Minerals
$9.25 /

-0.415 (-4.29%)

TDG TransDigm
$488.85 /

-16.92 (-3.35%)

VOXX VOXX
$7.76 /

-0.84 (-9.77%)

GES Guess
$12.40 /

-1.34 (-9.75%)

NVDA Nvidia
$491.00 /

+3.63 (+0.74%)

AM Antero Midstream
$5.29 /

-0.12 (-2.22%)

PTON Peloton
$93.00 /

+3.215 (+3.58%)

RVLV Revolve Group
$17.15 /

-0.17 (-0.98%)

Periodicals
Voodoo wins ruling in legal fight against Zynga unit, FT reports » 14:45
09/21/20
09/21
14:45
09/21/20
14:45
ZNGA

Zynga

$8.54 /

+0.08 (+0.95%)

, TCEHY

Tencent

$0.00 /

+ (+0.00%)

French mobile games maker…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZNGA Zynga
$8.54 /

+0.08 (+0.95%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

ZNGA Zynga
$8.54 /

+0.08 (+0.95%)

11:53 Today Baird
Bethesda deal 'checks a lot of boxes' for Microsoft, says Baird
08/19/20 Jefferies
Zynga remains Top Pick at Jefferies, sees a path to $13
08/11/20
Fly Intel: Top five analyst downgrades
08/11/20 Berenberg
Zynga downgraded to Hold from Buy at Berenberg
TCEHY Tencent
$0.00 /

+ (+0.00%)

08/13/20 Benchmark
Tencent price target raised to HK$575 from HK$560 at Benchmark
08/03/20 Morgan Stanley
Sohu.com named a Research Tactical Idea at Morgan Stanley
07/27/20 Barclays
Tencent price target raised to $75 from $63 at Barclays
07/14/20 Citi
Tencent price target raised to HK$649 from HK$541 at Citi
ZNGA Zynga
$8.54 /

+0.08 (+0.95%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

  • 07
    Aug
ZNGA Zynga
$8.54 /

+0.08 (+0.95%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

ZNGA Zynga
$8.54 /

+0.08 (+0.95%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

ZNGA Zynga
$8.54 /

+0.08 (+0.95%)

Periodicals
2020 Emmys draws new record low 6.1M viewers, CNN reports » 14:40
09/21/20
09/21
14:40
09/21/20
14:40
DIS

Disney

$124.37 /

-4.26 (-3.31%)

, CMCSA

Comcast

$43.57 /

-1.69 (-3.73%)

, CMCSK

Comcast

$0.00 /

+ (+0.00%)

, T

AT&T

$28.32 /

-0.6 (-2.07%)

This year's Emmy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DIS Disney
$124.37 /

-4.26 (-3.31%)

CMCSA Comcast
$43.57 /

-1.69 (-3.73%)

CMCSK Comcast
$0.00 /

+ (+0.00%)

T AT&T
$28.32 /

-0.6 (-2.07%)

DIS Disney
$124.37 /

-4.26 (-3.31%)

09/14/20 Jefferies
ESPN deal positive for both Caesars and DraftKings, says Jefferies
09/14/20 Evercore ISI
ESPN deal could add up to material dollars for DraftKings, says Evercore
09/08/20
Fly Intel: Top five analyst upgrades
09/08/20 Deutsche Bank
Disney upgraded to Buy from Hold at Deutsche Bank
CMCSA Comcast
$43.57 /

-1.69 (-3.73%)

09/18/20 Rosenblatt
Rosenblatt would be buyer on any Roku weakness amid latest Comcast 'tiff'
09/16/20 Pivotal Research
Comcast price target raised to $60 from $52 at Pivotal Research
08/24/20 BWS Financial
Xperi initiated with a Buy at BWS Financial
08/03/20 Deutsche Bank
Comcast price target raised to $53 from $47 at Deutsche Bank
CMCSK Comcast
$0.00 /

+ (+0.00%)

09/16/20 Pivotal Research
Comcast price target raised to $60 from $52 at Pivotal Research
07/01/20
Fly Intel: Top five analyst upgrades
04/28/20 Wells Fargo
SeaWorld price target lowered to $16 from $36 at Wells Fargo
04/17/20 Oppenheimer
Comcast downgraded to Perform from Outperform at Oppenheimer
T AT&T
$28.32 /

-0.6 (-2.07%)

08/31/20
Fly Intel: Top five analyst downgrades
08/31/20 Scotiabank
Scotiabank downgrades AT&T to Underperform on spectrum costs, share losses
08/31/20 Scotiabank
AT&T downgraded to Underperform from Sector Perform at Scotiabank
07/24/20 RBC Capital
AT&T price target lowered to $32 from $38 at RBC Capital
DIS Disney
$124.37 /

-4.26 (-3.31%)

CMCSA Comcast
$43.57 /

-1.69 (-3.73%)

CMCSK Comcast
$0.00 /

+ (+0.00%)

T AT&T
$28.32 /

-0.6 (-2.07%)

DIS Disney
$124.37 /

-4.26 (-3.31%)

CMCSA Comcast
$43.57 /

-1.69 (-3.73%)

CMCSK Comcast
$0.00 /

+ (+0.00%)

T AT&T
$28.32 /

-0.6 (-2.07%)

DIS Disney
$124.37 /

-4.26 (-3.31%)

CMCSA Comcast
$43.57 /

-1.69 (-3.73%)

CMCSK Comcast
$0.00 /

+ (+0.00%)

T AT&T
$28.32 /

-0.6 (-2.07%)

DIS Disney
$124.37 /

-4.26 (-3.31%)

CMCSA Comcast
$43.57 /

-1.69 (-3.73%)

T AT&T
$28.32 /

-0.6 (-2.07%)

Recommendations
Illumina's GRAIL deal 'an unclear fit' with core competencies, says Cowen » 14:33
09/21/20
09/21
14:33
09/21/20
14:33
ILMN

Illumina

$267.98 /

-27.31 (-9.25%)

Cowen analyst Dough…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ILMN Illumina
$267.98 /

-27.31 (-9.25%)

ILMN Illumina
$267.98 /

-27.31 (-9.25%)

06:11 Today Guggenheim
Illumina upgraded to Buy from Neutral at Guggenheim
09/17/20 Citi
Citi does not see strategic rationale in Illumina acquiring Grail
09/09/20 Morgan Stanley
Illumina initiated with an Equal Weight at Morgan Stanley
09/08/20 Canaccord
Illumina Hold rating maintained despite COVID-19 opportunity, says Canaccord
ILMN Illumina
$267.98 /

-27.31 (-9.25%)

ILMN Illumina
$267.98 /

-27.31 (-9.25%)

ILMN Illumina
$267.98 /

-27.31 (-9.25%)

ILMN Illumina
$267.98 /

-27.31 (-9.25%)

Recommendations
Tisotumab data sets Seattle Genetics up for another approval, says Piper Sandler » 14:25
09/21/20
09/21
14:25
09/21/20
14:25
SGEN

Seattle Genetics

$177.87 /

-3.29 (-1.82%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SGEN Seattle Genetics
$177.87 /

-3.29 (-1.82%)

SGEN Seattle Genetics
$177.87 /

-3.29 (-1.82%)

09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/15/20 SVB Leerink
Seattle Genetics price target raised to $185 from $173 at SVB Leerink
09/15/20 RBC Capital
Seattle Genetics price target raised to $191 from $175 at RBC Capital
09/14/20 RBC Capital
Seattle Genetics price target raised to $191 from $175 at RBC Capital
SGEN Seattle Genetics
$177.87 /

-3.29 (-1.82%)

SGEN Seattle Genetics
$177.87 /

-3.29 (-1.82%)

Conference/Events
Kirby participates in a conference call with Jefferies » 14:25
09/21/20
09/21
14:25
09/21/20
14:25
KEX

Kirby

$38.03 /

-1.62 (-4.09%)

Shipping Analyst Giveans…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KEX Kirby
$38.03 /

-1.62 (-4.09%)

KEX Kirby
$38.03 /

-1.62 (-4.09%)

07/15/20 OTR Global
U.S. Tank Barge Shipping downgraded to Negative from Mixed at OTR Global
04/16/20 Benchmark
Benchmark starts Kirby at Buy with $65 price target
04/16/20 Benchmark
Kirby initiated with a Buy at Benchmark
04/15/20 OTR Global
U.S. tank barge shipping market view lowered to mixed at OTR Global
KEX Kirby
$38.03 /

-1.62 (-4.09%)

Conference/Events
Jefferies software/Internet analyst to hold an analyst/industry conference call » 14:25
09/21/20
09/21
14:25
09/21/20
14:25

Software & Internet…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Truist biotech analysts to hold an analyst/industry conference call » 14:25
09/21/20
09/21
14:25
09/21/20
14:25

Biotechnology Analysts,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Periodicals
CDC pulls guidelines saying COVID-19 can spread from tiny particles, WSJ says » 14:23
09/21/20
09/21
14:23
09/21/20
14:23
SPX

S&P 500

$0.00 /

+ (+0.00%)

, SPY

SPDR S&P 500 ETF Trust

$323.28 /

-7.39 (-2.23%)

The U.S. Centers for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$323.28 /

-7.39 (-2.23%)

SPX S&P 500
$0.00 /

+ (+0.00%)

09/01/20
Fed's Brainard says monetary policy to pivot from stabilization to accommodation
08/17/20 Goldman Sachs
Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000
06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
SPY SPDR S&P 500 ETF Trust
$323.28 /

-7.39 (-2.23%)

09/01/20
Fed's Brainard says monetary policy to pivot from stabilization to accommodation
08/17/20 Goldman Sachs
Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000
06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$323.28 /

-7.39 (-2.23%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$323.28 /

-7.39 (-2.23%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$323.28 /

-7.39 (-2.23%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$323.28 /

-7.39 (-2.23%)

Technical Analysis
NASDAQ market internals summary » 14:17
09/21/20
09/21
14:17
09/21/20
14:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.